Hepatitis B surface antibodies can help a doctor identify different phases of hepatitis B infection and determine whether a person is immune to the virus or susceptible to infection.

In an in-vitro test (i.e. in a petri dish), the researchers saw that both CoV2-biRN antibodies retained their ability to neutralize multiple variants of the COVID-19 virus.

Test results for hepatitis B can seem confusing, but they don't have to be. Let's review what the presence or absence or these antibodies means for you: ...

According to a statement from White House press secretary Kayleigh McEnany, Trump received an 8-gram dose of the polyclonal antibody cocktail, REGN-COV2, from pharmaceutical company Regeneron, as ...

A hepatitis B nonreactive test result can mean a person is not immune to the virus. Learn how the test works, how to interpret the results, and the next steps.

To improve our understanding of the antibody response conferring protection against HBV infection, scientists have produced and characterized human monoclonal antibodies specific to viral envelope ...

Regeneron has confirmed it provided the experimental antibody cocktail REGN-COV2 to the White House under a compassionate use request, which allows a patient who has a life-threatening condition ...

HBV and HIVenv chips with overlapping oligopeptides encompassing the full amino acid sequences of HBV and HIV polypeptides were produced. In addition, a chip displaying a library of random 4608 ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing COVID-19 treatment strategies.

The effectiveness of the engineered investigational human monoclonal antibody VIR-3434 in inhibiting viral spread in hepatitis B and D viruses demonstrated.

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple COVID-19 variants.